XM non fornisce servizi ai residenti degli Stati Uniti d'America.

U.S. BioNTech, Honeywell International, Klaviyo



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>U.S. RESEARCH ROUNDUP-BioNTech, Honeywell International, Klaviyo</title></head><body>

June 12 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biontech, Honeywell International and Klaviyo, on Wednesday.


HIGHLIGHTS

* BioNTech SE BNTX.O: JP Morgan raises target price to $94 from $90

* Honeywell International Inc HON.O: HSBC raises target price to $235 from $200

* Klaviyo Inc KVYO.N: Barclays raises to overweight from equal weight

* NetApp Inc NTAP.O: Susquehanna raises target price to $155 from $138

* Welltower Inc WELL.N: Scotiabank raises target price to $110 from $108


Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.


* Academy Sports and Outdoors Inc ASO.O: Evercore ISI cuts target price to $60 from $70

* Academy Sports and Outdoors Inc ASO.O: Guggenheim cuts target price to $65 from $75

* Academy Sports and Outdoors Inc ASO.O: Jefferies cuts target price to $68 from $81

* Academy Sports and Outdoors Inc ASO.O: Morgan Stanley cuts target price to $60 from $65

* Academy Sports and Outdoors Inc ASO.O: TD Cowen cuts target price to $58 from $82

* Academy Sports and Outdoors Inc ASO.O: Telsey Advisory Group cuts PT to $65 from $75

* Academy Sports and Outdoors Inc ASO.O: Truist Securities cuts PT to $60 from $73

* Academy Sports and Outdoors Inc ASO.O: UBS cuts target price to $58 from $81

* Academy Sports and Outdoors Inc ASO.O: UBS cuts to neutral from buy

* Academy Sports and Outdoors Inc ASO.O: Wedbush cuts target price to $65 from $80

* Academy Sports and Outdoors Inc ASO.O: Wells Fargo cuts target price to $55 from $80

* Academy Sports and Outdoors Inc ASO.O: Wells Fargo cuts to equal weight from overweight

* Addus Homecare Corp ADUS.O: BofA Global Research resumes coverage with buy rating

* Addus Homecare Corp ADUS.O: BofA Global Research resumes coverage with price objective $135

* Agco Corporation AGCO.N: Oppenheimer cuts target price to $133 from $145

* Agree Realty Corp ADC.N: KeyBanc initiates coverage with overweight rating and $68 PT

* Apellis Pharmaceuticals Inc APLS.O: JP Morgan cuts target price to $72 from $79

* Aramark ARMK.N: Oppenheimer raises target price to $39 from $36

* Autodesk Inc ADSK.O: Barclays cuts target price to $275 from $310

* Autodesk Inc ADSK.O: BMO cuts target price to $254 from $293

* Autodesk Inc ADSK.O: Citigroup raises target price to $295 from $286

* Autodesk Inc ADSK.O: Deutsche Bank cuts target price to $245 from $265

* Autodesk Inc ADSK.O: JP Morgan cuts target price to $245 from $260

* Avidity Biosciences Inc RNA.O: Chardan Capital Markets raises PT to $45 from $33

* BioNTech SE BNTX.O: JP Morgan raises target price to $94 from $90

* Bloom Energy Corp BE.N: RBC raises target price to $15 from $14

* Broadstone Net Lease Inc BNL.N: KeyBanc initiates coverage with sector weight rating

* Brown-Forman Corp BFb.N: Truist Securities cuts target price to $50 from $80

* Caseys General Stores Inc CASY.O: RBC raises target price to $361 from $322

* Celsius Holdings Inc CELH.O: Morgan Stanley cuts target price to $68 from $75

* Celsius Holdings Inc CELH.O: Stifel cuts target price to $85 from $95

* Celsius Holdings Inc CELH.O: Wedbush cuts target price to $83 from $85

* Clearway Energy Inc CWENa.N: CIBC raises target price to $32 from $31

* Comerica Inc CMA.N: RBC cuts target price to $58 from $62

* Comerica Inc CMA.N: Truist Securities cuts target price to $55 from $60

* Darden Restaurants Inc DRI.N: Morgan Stanley cuts target price to $175 from $180

* Darden Restaurants Inc. DRI.N: Morgan Stanley cuts target price to $175.00 from $180.00

* Darling Ingredients Inc DAR.N: Citigroup cuts target price to $48 from $50

* Darling Ingredients Inc DAR.N: Citigroup raises to buy from neutral

* DXC Technology Co DXC.N: Susquehanna raises target price to $19 from $15

* Element Solutions Inc ESI.N: BMO raises target price to $30 from $28

* Element Solutions Inc ESI.N: Mizuho raises target price to $29 from $28

* Energy Fuels Inc. UUUU.A: H.C. Wainwright raises target price to $10.75 from $10

* Expeditors International of Washington Inc EXPD.N: BofA Global Research raises price objective to $131 from $126

* First Solar Inc FSLR.O: Baird raises target price to $344 from $246

* First Solar Inc FSLR.O: Oppenheimer raises target price to $325 from $271

* Fiserv Inc FI.N: Wells Fargo initiates coverage with overweight rating; PT $180

* Fortinet Inc FTNT.O: BofA Global Research removes stock from its US 1 list

* Funko Inc FNKO.O: D.A. Davidson raises target price to $12 from $10.5

* Gamestop Corp GME.N: Wedbush cuts target price to $11 from $13.5

* Global Payments Inc GPN.N: Wells Fargo initiates with equal weight rating; PT $100

* Haemonetics Corp HAE.N: Needham raises to buy from hold

* Harley-Davidson Inc HOG.N: Citigroup cuts target price to $34 from $36

* Honeywell International Inc HON.O: HSBC raises target price to $235 from $200

* Intra-Cellular Therapies Inc ITCI.O: JP Morgan raises target price to $78 from $75

* Kinder Morgan Inc KMI.N: UBS raises target price to $24 from $22

* Klaviyo Inc KVYO.N: Barclays raises target price to $29 from $25

* Klaviyo Inc KVYO.N: Barclays raises to overweight from equal weight

* Mama'S Creations Inc MAMA.O: Craig-Hallum raises target price to $9 from $8

* Manitowoc Company Inc MTW.N: UBS cuts target price to $14.5 from $18

* McCormick & Company Inc MKC.N: Citigroup raises target price to $69 from $68

* McCormick & Company Inc MKC.N: Citigroup raises to neutral from sell

* MKS Instruments Inc MKSI.O: TD Cowen raises target price to $160 from $150

* Moderna Inc MRNA.O: JP Morgan raises target price to $96 from $85

* Moderna Inc MRNA.O: Oppenheimer raises target price to $179 from $163

* Monster Beverage Corp MNST.O: Roth MKM cuts target price to $56 from $59

* NCR Voyix Corp VYX.N: Stifel initiates coverage With Buy rating; target price $16

* NetApp Inc NTAP.O: JP Morgan raises target price to $130 from $125

* NetApp Inc NTAP.O: Morgan Stanley raises target price to $127 from $106

* NetApp Inc NTAP.O: Stifel raises target price to $138 from $130

* NetApp Inc NTAP.O: Susquehanna raises target price to $155 from $138

* NetApp Inc NTAP.O: TD Cowen raises target price to $145 from $135

* Neurocrine Biosciences Inc NBIX.O: JP Morgan raises target price to $169 from $158

* Nextera Energy Inc NEE.N: BMO raises target price to $79 from $78

* Nextera Energy Inc NEE.N: Guggenheim raises target price to $83 from $82

* Nextera Energy Inc NEE.N: Mizuho cuts to neutral from buy

* Nextera Energy Inc NEE.N: RBC raises target price to $84 from $74

* Nextera Energy Partners LP NEP.N: CIBC raises target price to $35 from $34

* Nextera Energy Partners LP NEP.N: Mizuho cuts to neutral from buy

* Old Dominion Freight Line, Inc. ODFL.O: Barclays cuts target price to $195 from $205

* Oracle Corp ORCL.N: Barclays raises target price to $160 from $147

* Oracle Corp ORCL.N: Barclays raises target price to $160 from $147

* Oracle Corp ORCL.N: Bernstein raises target price to $171 from $159

* Oracle Corp ORCL.N: BofA Global Research raises price objective to $155 from $144

* Oracle Corp ORCL.N: Evercore ISI raises target price to $160 from $145

* Oracle Corp ORCL.N: Guggenheim raises target price to $175 from $150

* Oracle Corp ORCL.N: JP Morgan raises target price to $110 from $105

* Oracle Corp ORCL.N: Morgan Stanley raises target price to $125 from $115

* Oracle Corp ORCL.N: Stifel raises target price to $135 from $120

* Oracle Corp ORCL.N: TD Cowen raises target price to $165 from $145

* Oracle Corp ORCL.N: UBS raises target price to $160 from $150

* Oracle Corporation ORCL.N: Morgan Stanley raises target price to $125.00 from $115.00

* Pagerduty, Inc. PD.N: Craig-Hallum raises target price to $30 from $21

* Pagerduty, Inc. PD.N: Craig-Hallum raises to buy from hold

* Pepsico Inc. PEP.O: Barclays cuts target price to $180 from $185

* Petmed Express Inc PETS.O: Morgan Stanley cuts target price to $3.5 from $6.5

* Procore Technologies Inc PCOR.N: TD Cowen initiates coverage with buy rating; PT $85

* Protagonist Therapeutics Inc PTGX.O: JP Morgan raises target price to $39 from $37

* Realty Income Corp O.N: KeyBanc initiates coverage with sector weight rating

* Regeneron Pharmaceuticals Inc REGN.O: RBC raises target price to $1,229 from $1,200

* Rockwell Automation Inc ROK.N: Daiwa Capital Markets cuts target price to $295 from $305

* Rubrik, Inc. RBRK.N: Barclays raises target price to $42 from $41

* Salesforce Inc CRM.N: BofA Global Research removes stock from its US 1 list

* Sherwin-Williams Co SHW.N: BMO cuts target price to $360 from $377

* Skechers USA Inc SKX.N: Wells Fargo initiates coverage with overweight rating

* Skechers USA Inc SKX.N: Wells Fargo initiates coverage with price target $83

* Southwest Airlines Co LUV.N: TD Cowen raises target price to $26 from $25

* Springworks Therapeutics Inc SWTX.O: JP Morgan cuts target price to $64 from $77

* Teladoc Health Inc TDOC.N: Deutsche Bank cuts target price to $15 from $16

* Ultragenyx Pharmaceutical Inc RARE.O: JP Morgan raises target price to $94 from $92

* United Therapeutics Corp UTHR.O: Wells Fargo raises target price to $350 from $325

* Ventas Inc VTR.N: Scotiabank raises target price to $52 from $51

* Vornado Realty Trust VNO.N: BMO cuts target price to $29 from $31

* Welltower Inc WELL.N: Scotiabank raises target price to $110 from $108

* Zai Lab Ltd ZLAB.O: JP Morgan raises target price to $43 from $38

* Ziprecruiter Inc ZIP.N: UBS cuts target price to $11 from $13


(Compiled by Bengaluru Newsroom)

</body></html>

Disclaimer: le entità di XM Group forniscono servizi di sola esecuzione e accesso al nostro servizio di trading online, che permette all'individuo di visualizzare e/o utilizzare i contenuti disponibili sul sito o attraverso di esso; non ha il proposito di modificare o espandere le proprie funzioni, né le modifica o espande. L'accesso e l'utilizzo sono sempre soggetti a: (i) Termini e condizioni; (ii) Avvertenza sui rischi e (iii) Disclaimer completo. Tali contenuti sono perciò forniti a scopo puramente informativo. Nello specifico, ti preghiamo di considerare che i contenuti del nostro servizio di trading online non rappresentano un sollecito né un'offerta ad operare sui mercati finanziari. Il trading su qualsiasi mercato finanziario comporta un notevole livello di rischio per il tuo capitale.

Tutto il materiale pubblicato sul nostro servizio di trading online è unicamente a scopo educativo e informativo, e non contiene (e non dovrebbe essere considerato come contenente) consigli e raccomandazioni di carattere finanziario, di trading o fiscale, né informazioni riguardanti i nostri prezzi di trading, offerte o solleciti riguardanti transazioni che possano coinvolgere strumenti finanziari, oppure promozioni finanziarie da te non richieste.

Tutti i contenuti di terze parti, oltre ai contenuti offerti da XM, siano essi opinioni, news, ricerca, analisi, prezzi, altre informazioni o link a siti di terzi presenti su questo sito, sono forniti "così com'è", e vanno considerati come commenti generali sui mercati; per questo motivo, non possono essere visti come consigli di investimento. Dato che tutti i contenuti sono intesi come ricerche di investimento, devi considerare e accettare che non sono stati preparati né creati seguendo i requisiti normativi pensati per promuovere l'indipendenza delle ricerche di investimento; per questo motivo, questi contenuti devono essere considerati come comunicazioni di marketing in base alle leggi e normative vigenti. Assicurati di avere letto e compreso pienamente la nostra Notifica sulla ricerca di investimento non indipendente e la nostra Informativa sul rischio riguardante le informazioni sopra citate; tali documenti sono consultabili qui.

Avvertenza sul rischio: Il tuo capitale è a rischio. I prodotti con leva finanziaria possono non essere adatti a tutti. Ti chiediamo di consultare attentamente la nostra Informativa sul rischio.